Abstract 2845
Background
Adolescents and young adults (AYA) with cancer represent a unique demographic with distinctive developmental and psychosocial pressures. We sought to understand the baseline psychosocial needs of AYAs compared to case matched older adults at diagnosis using the Canadian Problem Checklist (CPC) and the Psychosocial Screen for Cancer - Revised (PSSCAN-R). The CPC is a tool to identify patient concerns in six domains: emotional, practical, spiritual, social, informational and physical. The PSSCAN-R is a validated tool to assess psychosocial needs and distress.
Methods
All AYA patients who completed the CPC and PSSCAN-R within 6 months of their cancer diagnosis between 2011-2016 in the province of British Columbia, Canada were included in the study. Baseline demographics were collected through retrospective chart review. A 3:1 case match based on gender, primary tumor site and metastatic status was performed with older adults (>40 years old) and AYA (18-40 years old). Statistical analysis was undertaken through Chi squared and Fisher’s exact test.
Results
2045 AYAs were case matched by common AYA tumor sites with 6050 older adults. Top five tumor sites were breast (20.4%), lymphoma (11.5%), gastrointestinal (10.8%), thyroid (10.6%), cervix/endometrium (8.0%). 61.9% were female and 12.1% had metastatic disease at diagnosis. The top 6 concerns for AYAs (% AYA, % older adults) were: fear/worry (56.6, 42.9) understanding of illness (47.6, 41.4), sleep (35.2, 28.9), sadness (34.1, 20.0), finances (33.8, 15.0), school/work (33.7, 10.5), all p < 0.01. AYAs reported higher anxiety at baseline (% AYA, % older adults): subclinical (26.0, 19.9), clinical (26.6, 17.1), p < 0.01.
Conclusions
Significant differences in baseline psychosocial needs for AYAs exist across multiple domains. Specifically, higher emotional, financial, school/work distress and baseline anxiety scores. Tailored support with early focus on these domains would benefit this unique and under-served population.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
4526 - Long-term outcome of neoadjuvant tyrosine kinase inhibitors (TKI) in locally advanced dermatofibrosarcoma protuberans (DFSP)
Presenter: Jessica Beaziz
Session: Poster Display session 1
Resources:
Abstract
1214 - Neo-adjuvant (NA) Imatinib for gastrointestinal stromal tumours (GISTs): What is the optimal length of treatment?
Presenter: Tom Wilson
Session: Poster Display session 1
Resources:
Abstract
2690 - Gastrointestinal Stromal Tumours (GIST) in adolescents and young adults (AYA)
Presenter: Nikki Ijzerman
Session: Poster Display session 1
Resources:
Abstract
4558 - Radiomics improves response evaluation for desmoid tumors treated with chemotherapy
Presenter: Amandine Crombe
Session: Poster Display session 1
Resources:
Abstract
2751 - Radiomics of gastrointestinal stromal tumors; risk classification based on computed tomography images – a pilot study
Presenter: Milea Timbergen
Session: Poster Display session 1
Resources:
Abstract
2737 - Differentiating well-differentiated liposarcomas from lipomas using a radiomics approach
Presenter: Melissa Vos
Session: Poster Display session 1
Resources:
Abstract
1282 - The immune landscape of chondrosarcoma reveals an anti inflammatory environment
Presenter: Iseulys Richert
Session: Poster Display session 1
Resources:
Abstract
1572 - Impact of Immunotherapy and Targeted Therapy on Tumor Growth Rate in Sarcoma
Presenter: Esmail Al-ezzi
Session: Poster Display session 1
Resources:
Abstract
3414 - DNA methylation profiles of angiosarcoma subtypes.
Presenter: Marije Weidema
Session: Poster Display session 1
Resources:
Abstract
3411 - Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As and BTN3A1 in patients with metastatic gastrointestinal stromal tumors (mGISTs)
Presenter: Daniele Fanale
Session: Poster Display session 1
Resources:
Abstract